Ownes & Minor (NYSE: OMI) reported Q1 EPS of $0.43, $0.04 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $2.37 billion versus the consensus estimate of $2.4 billion.

• O&M completes acquisition of Halyard Health’s Surgical & Infection Prevention (S&IP) business
• Consolidated quarterly revenues were $2.37 billion vs. $2.33 billion a year ago
• EPS for the quarter was $0.13, while non-GAAP adjusted EPS was $0.43

“We are pleased to have completed the acquisition of Halyard Health’s S&IP business, which represents a meaningful step in the evolution of our business. Together, the Halyard S&IP business and Byram Healthcare serve to strengthen and diversify our business model,” said P. Cody Phipps, chairman, president & chief executive officer of Owens & Minor. “Our quarterly results improved sequentially, consistent with our expectations, as we continued to transform our business. By combining the Halyard S&IP business with our existing products group, our Global Products strategic business unit has an enhanced presence in the medical products sector with approximately $1.5 billion in annualized revenues. This transaction gives Owens & Minor a global platform for growth with a strong product portfolio and exceptional teammates.”

For earnings history and earnings-related data on Ownes & Minor (OMI) click here.